Detalhe da pesquisa
1.
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.
Mult Scler
; 30(7): 833-842, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38619037
2.
Characterizing lymphocyte counts and infection rates with long-term teriflunomide treatment: Pooled analysis of clinical trials.
Mult Scler
; 26(9): 1083-1092, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31172849
3.
Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience.
Mult Scler
; 26(7): 829-836, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30968734
4.
The efficacy of teriflunomide in patients who received prior disease-modifying treatments: Subgroup analyses of the teriflunomide phase 3 TEMSO and TOWER studies.
Mult Scler
; 24(4): 535-539, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-28304217
5.
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Mult Scler
; 20(6): 705-16, 2014 May.
Artigo
Inglês
| MEDLINE | ID: mdl-24126064
6.
Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.
Clin Transl Sci
; 17(1): e13690, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38010108
7.
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial.
Lancet Neurol
; 20(12): 1001-1011, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34800398
8.
(18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.
Eur J Nucl Med Mol Imaging
; 37(6): 1095-105, 2010 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-20204358
9.
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.
Mult Scler Relat Disord
; 46: 102438, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-32911306
10.
Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER study.
J Clin Neurosci
; 59: 229-231, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30348586
11.
Teriflunomide real-world evidence: Global differences in the phase 4 Teri-PRO study.
Mult Scler Relat Disord
; 31: 157-164, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-31005729
12.
Long-term outcomes with teriflunomide in patients with clinically isolated syndrome: Results of the TOPIC extension studyâ â .
Mult Scler Relat Disord
; 33: 131-138, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31195337
13.
Desmoplastic neurotropic melanoma in a patient with trigeminal neuralgia: FDG PET/CT and MRI.
Clin Nucl Med
; 33(5): 353-5, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18431156
14.
Patient-reported outcomes in patients with relapsing forms of MS switching to teriflunomide from other disease-modifying therapies: Results from the global Phase 4 Teri-PRO study in routine clinical practice.
Mult Scler Relat Disord
; 26: 211-218, 2018 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-30273841
15.
Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study.
Mult Scler Relat Disord
; 17: 107-115, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29055438
16.
Long-term safety and efficacy of teriflunomide: Nine-year follow-up of the randomized TEMSO study.
Neurology
; 86(10): 920-30, 2016 Mar 08.
Artigo
Inglês
| MEDLINE | ID: mdl-26865517
17.
Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions.
Mult Scler Relat Disord
; 5: 97-104, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26856952
18.
Randomized study of teriflunomide effects on immune responses to neoantigen and recall antigens.
Neurol Neuroimmunol Neuroinflamm
; 2(2): e70, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25738167
19.
Impact of internal mammary sentinel node imaging in breast cancer.
Clin Nucl Med
; 28(5): 375-8, 2003 May.
Artigo
Inglês
| MEDLINE | ID: mdl-12702932
20.
Pregnancy outcomes following maternal and paternal exposure to teriflunomide during treatment for relapsing-remitting multiple sclerosis.
Neurol Ther
; 3(2): 133-8, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26000229